Almac Announces Launch of IXRS® 2.0 Next Generation Clinical Technology
Almac announced the launch of its IXRS® 2.0 integrated, interactive voice (IVR) and web response (IWR) technology.
IXRS® 2.0 aims to improve the user experience through enhanced web functionality, such as smart menus and intuitive task management. Almac will showcase IXRS® 2.0 at the upcoming DIA Annual Meeting, held June 13 – 17, 2010, in Washington, D.C.
Jim Murphy, President of Almac’s Clinical Technologies division comments: “Almac was the pioneer of integrated phone and Web platform technology in our industry when we released IXRS® in 2006. Since then, we have added new features and functionalities each yeart. Since over 50% of IXRS® transactions are now conducted online, we have added smart menus and informed navigation, along with other key features to improve the user experience and improve the quality of data we collect for biopharmaceutical clients.”
IXRS® 2.0 smart menu technology presents users with valid options only and guides them to correct choices, directing their workflow. Moreover, smart menus reduce manual data entry and hence improve data quality by reducing the likelihood of human error. Leveraging informed navigation, site and sponsor personnel can easily manage subject data, visit schedules, kit assignments, drug supply strategies, expiration dates, drug holds, recalls, shipment releases, temperature excursions, and re-labeling of supplies.
IXRS® 2.0 was designed to facilitate many of the aspects of modern clinical trials. It features increased randomization functionality and cohort management capabilities for adaptive and other complex trial designs, helping to shorten timelines on such studies. Additionally, IXRS® 2.0 offers several new features for cold chain management, temperature excursion tracking, and other vital functions to ensure that expensive biologics are closely monitored and are not wasted.
Almac will showcase IXRS® 2.0 and Almac Interactive Reporting at the DIA Conference, June 13-17. As sponsors and sites log-on to one portal to access both Almac Interactive Reporting and IXRS® 2.0, demos will show how users can interact with both technologies to enhance productivity and trial efficiencies.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
